Available in 10 markets
State Street® Global Dividend Spotlight Active Equity UCITS ETF (Acc)
State Street® Global Dividend Spotlight Active Equity UCITS ETF (Acc) is an exchange-traded fund (ETF) from SPDR, traded under the ticker GDSF (ISIN IE000KBUL630). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. In plain terms it is about owning small slices of companies, so you share in…
Opens the screener with this filter applied.
About this fund
What you own
The MSCI World High Dividend Yield Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 40 companies across Global in a single purchase.
Dividends
The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.
Read more
Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.
How it works
The fund actually buys every share in the index it tracks (full replication).
Read more
Owning every holding keeps things transparent — what is in the index is what the fund actually owns. It can be a touch costlier to run for indexes with thousands of tiny positions, since the fund has to buy and maintain them all. There is no swap bank involved, so there is no extra “what if the partner fails” question to weigh.
Cost
The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.
Read more
For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.
Fund facts
Performance
Growth of $100 invested — the line starts at $100.
End-of-day prices, rebased to a common start so the shapes are comparable. Past performance does not predict future results.
How bumpy has it been?
The bigger picture
What's inside
By sector ?
The 10 biggest holdings make up 34.5% of the fund — the rest is spread across roughly 30 more companies.
Top 10 holdings
| # | Company | Weight |
|---|---|---|
| 1 | Merck & Co. Inc. | 4.5% |
| 2 | ConocoPhillips | 3.8% |
| 3 | Publicis Groupe SA | 3.7% |
| 4 | Home Depot Inc. | 3.7% |
| 5 | BNP Paribas S.A. Class A | 3.6% |
| 6 | M&T Bank Corporation | 3.2% |
| 7 | Roche Holding Ltd | 3.2% |
| 8 | RPM International Inc. | 3.1% |
| 9 | Sanofi SA | 2.9% |
| 10 | Cigna Group | 2.9% |
Where to buy this fund
Set from your language & location — change it if it's wrong.
Where it trades
| Exchange | Ticker | Currency | |
|---|---|---|---|
| Frankfurt | GDSF | EUR | ★ Primary |
| USD listings | |||
| E1 | GDSFEUR | USD | |
| EO | GDSFEUR | USD | |
| EP | GDSFEUR | USD | |
| EU | GDSFEUR | USD | |
| EZ | GDSFEUR | USD | |
| GD | GDSF | USD | |
| GF | GDSF | USD | |
| GM | GDSF | USD | |
| GT | GDSF | USD | |
| GZ | GDSF | USD | |
| London Stock Exchange | GDSF | USD | |
| QT | GDSF | USD | |
| TH | GDSF | USD | |
| X1 | GDSFEUR | USD | |
| X2 | GDSFEUR | USD | |
| XA | GDSFEUR | USD | |
| XF | GDSFEUR | USD | |
| XG | GDSFEUR | USD | |
| XH | GDSFEUR | USD | |
| XJ | GDSFEUR | USD | |
| XL | GDSFEUR | USD | |
| XO | GDSFEUR | USD | |
| XQ | GDSFEUR | USD | |
| XT | GDSFEUR | USD | |
| XU | GDSFEUR | USD | |
| XV | GDSFEUR | USD | |
| XW | GDSFEUR | USD | |
| XX | GDSFEUR | USD | |
| XY | GDSFEUR | USD | |
| XZ | GDSFEUR | USD | |
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows
Full holdings
As of 2026-08-19 · the fund's own published holdings.
| # | Company | Weight |
|---|---|---|
| 1 | Merck & Co. Inc. | 4.5% |
| 2 | ConocoPhillips | 3.8% |
| 3 | Publicis Groupe SA | 3.7% |
| 4 | Home Depot Inc. | 3.7% |
| 5 | BNP Paribas S.A. Class A | 3.6% |
| 6 | M&T Bank Corporation | 3.2% |
| 7 | Roche Holding Ltd | 3.2% |
| 8 | RPM International Inc. | 3.1% |
| 9 | Sanofi SA | 2.9% |
| 10 | Cigna Group | 2.9% |
| 11 | AstraZeneca PLC | 2.8% |
| 12 | TotalEnergies SE | 2.8% |
| 13 | Elevance Health Inc. | 2.8% |
| 14 | Sysco Corporation | 2.7% |
| 15 | ANDRITZ AG | 2.7% |
| 16 | Chevron Corporation | 2.6% |
| 17 | Bristol-Myers Squibb Company | 2.5% |
| 18 | CSL Limited | 2.5% |
| 19 | Volvo AB Class B | 2.5% |
| 20 | Toyota Motor Corp. | 2.5% |
| 21 | Nestle S.A. | 2.4% |
| 22 | A. O. Smith Corporation | 2.3% |
| 23 | Reckitt Benckiser Group plc | 2.3% |
| 24 | PT Bank Mandiri (Persero) Tbk | 2.3% |
| 25 | CNH Industrial NV | 2.3% |
| 26 | Reinsurance Group of America Incorporated | 2.2% |
| 27 | Enel SpA | 2.2% |
| 28 | Inner Mongolia Yili Industrial Group Co. Ltd. Class A | 2.2% |
| 29 | ConvaTec Group Plc | 1.9% |
| 30 | LVMH Moet Hennessy Louis Vuitton SE | 1.9% |
| 31 | CRH public limited company | 1.9% |
| 32 | Ryanair Holdings Plc | 1.8% |
| 33 | Glanbia Plc | 1.8% |
| 34 | Taiwan Semiconductor Manufacturing Co. Ltd. | 1.7% |
| 35 | Johnson & Johnson | 1.7% |
| 36 | Allianz SE | 1.6% |
| 37 | Devon Energy Corporation | 1.6% |
| 38 | Sodexo SA | 1.6% |
| 39 | Salesforce Inc. | 1.6% |
| 40 | Kingspan Group Plc | 1.5% |
How it ranks vs peers
Versus the Equity (stocks) · Global · EUR ETFs we track.
Advanced risk
Concentration depth
Roughly 40 companies are held, but the largest names carry most of the weight — so it behaves like ~37 equal-sized positions.
Tilt vs a world tracker
Percentage points over / under a broad world-equity tracker (not a licensed benchmark).
Documents
Similar funds
We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.
| State Street® Global Dividend Spotlight Active Equity UCITS ETF (Acc)SPDRYou're viewing | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | iShares Core MSCI World UCITS ETFiSharesBroader match | State Street® SPDR® Portfolio Developed World ex-US ETFSPDRBroader match | iShares MSCI ACWI UCITS ETFiSharesBroader match | |
|---|---|---|---|---|---|---|---|
| Why it's similar | This is the fund on this page. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksAccumulatingPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. | StocksPhysicalCheaper fee Tracks a different index in the same category. |
| Index tracked | MSCI World High Dividend Yield Index | MSCI World | MSCI World | MSCI World | MSCI World | S&P Developed Ex-U.S. BMI Index | MSCI ACWI |
| Yearly fee (TER) | 0.45% | 0.30% | 0.30% | 0.20% | 0.20% | 0.03% | 0.20% |
| All-in cost | 0.49% | 0.30% | 0.00% | 0.00% | 0.20% | 0.00% | 0.00% |
| Fund size | €4.9M | €166B | €146.5B | €128.1B | €127.6B | €35.6B | €30.7B |
| Domicile | Ireland | Ireland | Ireland | Ireland | Ireland | United States | Ireland |
| Replication | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) | Physical (full) |
| 3-yr return p.a. | +16.8% | +17.8% | +18.3% | +17.8% | |||
| 5-yr return p.a. | +9.7% | +9.3% | +11.3% | +7.1% | |||
| # holdings | 40 | 1,356 | 1,356 | 1,356 | 1,356 | 2,459 | 1,738 |
The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.
Open the full comparison tool →New to ETFs? Start with the basics →
Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.